2699 related articles for article (PubMed ID: 24138885)
1. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.
Bindea G; Mlecnik B; Tosolini M; Kirilovsky A; Waldner M; Obenauf AC; Angell H; Fredriksen T; Lafontaine L; Berger A; Bruneval P; Fridman WH; Becker C; Pagès F; Speicher MR; Trajanoski Z; Galon J
Immunity; 2013 Oct; 39(4):782-95. PubMed ID: 24138885
[TBL] [Abstract][Full Text] [Related]
2. A "big data" view of the tumor "immunome".
Restifo NP
Immunity; 2013 Oct; 39(4):631-2. PubMed ID: 24138879
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
Remark R; Alifano M; Cremer I; Lupo A; Dieu-Nosjean MC; Riquet M; Crozet L; Ouakrim H; Goc J; Cazes A; Fléjou JF; Gibault L; Verkarre V; Régnard JF; Pagès ON; Oudard S; Mlecnik B; Sautès-Fridman C; Fridman WH; Damotte D
Clin Cancer Res; 2013 Aug; 19(15):4079-91. PubMed ID: 23785047
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
[TBL] [Abstract][Full Text] [Related]
6. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
[TBL] [Abstract][Full Text] [Related]
7. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
9. Duality of B Cell-CXCL13 Axis in Tumor Immunology.
Rubio AJ; Porter T; Zhong X
Front Immunol; 2020; 11():521110. PubMed ID: 33193299
[TBL] [Abstract][Full Text] [Related]
10. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
[TBL] [Abstract][Full Text] [Related]
11. Tim-3 identifies exhausted follicular helper T cells in breast cancer patients.
Zhu S; Lin J; Qiao G; Wang X; Xu Y
Immunobiology; 2016 Sep; 221(9):986-93. PubMed ID: 27156907
[TBL] [Abstract][Full Text] [Related]
12. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
[TBL] [Abstract][Full Text] [Related]
13. The microenvironment in follicular lymphoma.
de Jong D; Fest T
Best Pract Res Clin Haematol; 2011 Jun; 24(2):135-46. PubMed ID: 21658614
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
15. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses.
Chevalier N; Jarrossay D; Ho E; Avery DT; Ma CS; Yu D; Sallusto F; Tangye SG; Mackay CR
J Immunol; 2011 May; 186(10):5556-68. PubMed ID: 21471443
[TBL] [Abstract][Full Text] [Related]
16. A fundamental role for interleukin-21 in the generation of T follicular helper cells.
Vogelzang A; McGuire HM; Yu D; Sprent J; Mackay CR; King C
Immunity; 2008 Jul; 29(1):127-37. PubMed ID: 18602282
[TBL] [Abstract][Full Text] [Related]
17. A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity.
McGuire HM; Vogelzang A; Ma CS; Hughes WE; Silveira PA; Tangye SG; Christ D; Fulcher D; Falcone M; King C
Immunity; 2011 Apr; 34(4):602-15. PubMed ID: 21511186
[TBL] [Abstract][Full Text] [Related]
18. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
19. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
[TBL] [Abstract][Full Text] [Related]
20. IL-21 enhances the potential of human γδ T cells to provide B-cell help.
Bansal RR; Mackay CR; Moser B; Eberl M
Eur J Immunol; 2012 Jan; 42(1):110-9. PubMed ID: 22009762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
